Page 1 | Search Results | The Hematologist | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Articles

The L-MIND Trial of the Anti-CD19 Antibody Tafasitamab Combined With Lenalidomide for Lower Risk Relapsed DLBCL

Michael Jain, MD, PhD, Frederick Locke, MD

The Hematologist (2020) 17 (5)

Published: 2020